Lapi Laboratories is primarily engaged in pharmaceutical preparations activity. Its headquarters is located in Dki Jakarta. The company was founded in 1973. Lapi Laboratories was founded by Dr. H. Soewandi, a visionary in the pharmaceutical industry. The company has established itself as a prominent player in the Indonesian pharmaceutical market, focusing on the development, production, and distribution of high-quality pharmaceutical products. The primary business line of Lapi Laboratories is the manufacturing of pharmaceutical preparations, with a secondary focus on research and development to innovate new drug formulations. The company offers a wide range of products, including prescription medications, over-the-counter drugs, and health supplements. Lapi Laboratories operates several branches across Indonesia, ensuring a strong local geographical footprint. The company has also expanded its operations to include export markets in Southeast Asia, enhancing its global presence. Some of the well-known product brands under Lapi Laboratories include LapiCough, LapiFlu, and LapiVita, which cater to various health needs such as respiratory, flu, and vitamin supplements. The company collaborates with several international pharmaceutical firms and is a member of various industry associations, which helps it stay at the forefront of pharmaceutical advancements. Lapi Laboratories is committed to improving public health and aims to be a leader in the pharmaceutical industry by providing innovative and affordable healthcare solutions. The company's mission is to enhance the quality of life through its dedication to research, quality, and customer satisfaction.
Headquarters
Kota Jakarta Utara Pluit Penjaringan Dki Jakarta
North Jakarta; Jakarta;
Postal Code: 14450
Contact Details: Purchase the PT Lapi Laboratories report to view the information.
Website: http://www.lapilaboratories.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service